cisatracurium besylate How Supplied/Storage and Handling

()

16 HOW SUPPLIED/STORAGE AND HANDLING

Cisatracurium Besylate Injection, USP is a clear solution supplied as follows:

Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:

Unit of SaleConcentration

NDC 0409-1098-02

10 mg/5 mL

Carton containing 10 Single-dose Vials

(2 mg/mL)

NDC 0409-1208-01

20 mg/10 mL

Carton containing 10 Multiple-dose Vials

(2 mg/mL)

NOTE: 10 mL Multiple-dose vials contain 0.9% w/v benzyl alcohol as a preservative [see Warnings and Precautions (5.2)].

Cisatracurium Besylate Injection, USP, 10 mg cisatracurium per mL is supplied in the following:

Unit of SaleConcentration

NDC 0409-1103-01

200 mg/20 mL

Carton containing 10 Single-dose Vials

(10 mg/mL)

Intended only for use in the ICU.

Discard unused portion of the 5 mL and 20 mL single-dose vials.

Storage

Cisatracurium Besylate Injection, USP should be refrigerated at 2°C to 8°C (36°F to 46°F) in the carton to preserve potency. Protect from light. DO NOT FREEZE. Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Cisatracurium Besylate Injection, USP within 21 days, even if re-refrigerated.

Find cisatracurium besylate medical information:

Find cisatracurium besylate medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

cisatracurium besylate Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

Cisatracurium Besylate Injection, USP is a clear solution supplied as follows:

Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:

Unit of SaleConcentration

NDC 0409-1098-02

10 mg/5 mL

Carton containing 10 Single-dose Vials

(2 mg/mL)

NDC 0409-1208-01

20 mg/10 mL

Carton containing 10 Multiple-dose Vials

(2 mg/mL)

NOTE: 10 mL Multiple-dose vials contain 0.9% w/v benzyl alcohol as a preservative [see Warnings and Precautions (5.2)].

Cisatracurium Besylate Injection, USP, 10 mg cisatracurium per mL is supplied in the following:

Unit of SaleConcentration

NDC 0409-1103-01

200 mg/20 mL

Carton containing 10 Single-dose Vials

(10 mg/mL)

Intended only for use in the ICU.

Discard unused portion of the 5 mL and 20 mL single-dose vials.

Storage

Cisatracurium Besylate Injection, USP should be refrigerated at 2°C to 8°C (36°F to 46°F) in the carton to preserve potency. Protect from light. DO NOT FREEZE. Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Cisatracurium Besylate Injection, USP within 21 days, even if re-refrigerated.
Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5Pm ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.